Clinical Trial: Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660198) titled 'Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents' on June 15.

Brief Summary: The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in children when compared to the pneumococcal vaccine that is currently in use, 20vPnC (Prevnar 20(R)).

This study will test if the new pneumococcal vaccine is as safe as the one that is currently in use. It will also assess ...